Vigilancia epidemiológica del síndrome de Down en Chile, 1972 a 2005

International audienceRoutledge, 2014, 422

Restricción del crecimiento intrauterino como factor de riesgo para malformaciones congénitas

Indexación: ScieloAntecedentes: La restricción del crecimiento intrauterino (RCIU) se estima que está presente en el 5% de los nacimientos y es la manifestación de procesos aberrantes que impiden el desarrollo normal del feto. Objetivos: Estimar la frecuencia de esta patología en la maternidad del Hospital Clínico de la Universidad de Chile. Obtener la tasa prevalencia al nacimiento de malformaciones congénitas (MFC) y comparar la frecuencia en recién nacidos pequeños (PEG) con los adecuados (AEG) y grandes (GEG) para la edad gestacional. Método: Se estudian todos los nacimientos, vivos y mortinatos, ocurridos entre enero de 1997 a diciembre de 2008, contenidos en la base de datos del ECLAMC (Estudio Colaborativo Latino Americano de Malformaciones Congénitas) desde 1969 a la fecha. Se excluyen los recién nacidos con malformaciones como hidrocefalia, anencefalia e hidrops, que por sus características dificultan la posibilidad de clasificación en PEG, AEG o GEG. Resultados: 10,1% de los nacimientos del período eran PEG. Entre los nacidos vivos 10% fueron PEG, mientras que 33,5% de los mortinatos eran PEG (p<0,05). Eran malformados el 12,9% de los PEG, 8,5% de los AEG y 9,3% de los GEG (p<0,05). La tasa global de malformaciones fue de 9,5%; en NV el 9,4% y en mortinatos el 33%. Conclusión: El RCIU es un factor que aumenta el riesgo de mortalidad fetal tardía y de presentar malformaciones congénitas.Background: Fetal growth restriction (FGR) is the result of anomalies that prevent the normal development of the fetus, it is present in about the 5% of births. Objectives: To estímate the frequency of FGR in the Clini-cal Hospital of the University of Chile. To estímate the congenital malformation prevalence rate at birth and compare it among small (SGE), adequate (AGE) and large (LGE) newborns according their gestational age. Methods: All live births and stillbirths included in the ECLAMC (Estudio Colaborativo Latino Americano de Malformaciones Congénitas) registered from January 1997 and December 2008 were considered. Newborns with congenital malformations that modified per se the size of the child, like hydrocephaly anencephaly and hydrops were excluded. Results: 10.1% of newborns were SGE. Among live births 10% were SGE instead of the 33.5% found in stillbirths (p<0.05). Congenital malformation rate at birth was 12.9% in SGE, 8.5% in AGE and 9.3% in LGE newborns (p<0.05). The global congenital malformation prevalence rate at birth was 9.5%; 9.4% in live newborns and 33% in stillbirth. Conclusión: The FGR increase the risk of late fetal mortality and congenital anomalies.http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262009000600008&nrm=is

Adverse outcomes of pregnancy and blood groups: A relationship with no importance?

Seeking a relationship between blood groups and successful pregnancy, Linn’s group carried out an analysis using the med- ical records of 11,659 women. They found a significantly higher frequency of bleeding during pregnancy among Rh(+) women, when compared with Rh(-) women. However, they concluded that this relationship is not important because it is due to confounding variables and not to the mother’s phenotype. It should be noticed that although we cannot say that there is a causal relationship, there is definitely a relationship between Rh phenotype and bleeding during pregnancy in the study published by Linn and co-workers. This relationship is important from an evolutionary standpoint and it suggests that the natural selection could be working more intensely against Rh(+) than against Rh(-) mothers. © 1994 S. Karger AG, Basel

Congenital malformations in Latin America in the period 1995-2008 Malformaciones congénitas en Chile y Latino América: Una visión epidemiológica del ECLAMC del período 1995-2008

Background: The Latin American Study of Congenital Malformations (ECLAMC) has performed an epidemiological surveillance of congenital malformations since 1967. This allows to detect any unexpected change in the incidence of malformations, possibly caused by a new environmental teratogenic agent. Aim: To report a summary of the results thus far obtained in this study. Material and Methods: The ECLAMC database was analyzed and all live births and stillbirths of more than 500 grams in the period 1995-2008, were analyzed. Results: There were 2,409,407 births in the nine participant countries. Of these 31,516 (1.3%) were stillbirths. The global rate of congenital malformations in this sample was 2.7%. In the studied period, there was a signifi cant reduction in the rates of anencephaly and spina bifi da in Chile and Argentina. In the rest of the countries, the global rates of malformations increased. Venezuela had the higher rate of teenage pregnancies (25%), followed by Colombia (23%). Ch

Prevalence of congenital malformations at birth in chilean maternity hospitals Prevalencia al nacimiento de malformaciones congénitas en las maternidades chilenas participantes en el ECLAMC en el período 2001-2010

© 2014, Sociedad Medica de Santiago. All rights reserved. Background: The Latin American Collaborative Study of Congenital Malformations (ECLAMC) is an epidemiological surveillance system operating in 11 South American countries since 1969. Aim: To analyze the Congenital Malformation prevalence rate at birth from 2001 to 2010 in Chilean Hospitals participating in ECLAMC. To compare these rates with those of the period 1982-1994. Material and Methods: Review of the ECLAMC database, which contains information about 282.568 newborns, 2.110 of them stillbirths (0.75%) from 13 Maternity hospitals. Results: In the study period, 10.925 newborns had congenital malformations (3.9 %). Their frequency was lower in live newborns than stillbirths (3.8 and 15.3%, respectively). Compared with the 1982-1994 period, congenital malformation prevalence rates at birth were higher. They stabilized in approximately 4 %, from 1985 to 2010. The prevalence of some anomalies such as Down syndrome increased sig